Source: ALL
Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
Crohn Disease
CUI: C0010346
Disease: Crohn Disease
0.800 GeneticVariation GWASCAT Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. 26192919 2015
Crohn Disease
CUI: C0010346
Disease: Crohn Disease
0.800 GeneticVariation GWASDB Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. 23128233 2012
Crohn Disease
CUI: C0010346
Disease: Crohn Disease
0.800 GeneticVariation GWASCAT Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. 23128233 2012
HIV-1, RESISTANCE TO
CUI: C1836231
Disease: HIV-1, RESISTANCE TO
0.800 GeneticVariation GWASCAT The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. 21051598 2010
AIDS, PROGRESSION TO
CUI: C1836233
Disease: AIDS, PROGRESSION TO
0.800 GeneticVariation GWASDB The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. 21051598 2010
HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO
0.800 GeneticVariation GWASCAT The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. 21051598 2010
ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO
0.800 GeneticVariation GWASDB The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. 21051598 2010
HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO
0.800 GeneticVariation GWASDB The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. 21051598 2010
HIV-1, RESISTANCE TO
CUI: C1836231
Disease: HIV-1, RESISTANCE TO
0.800 GeneticVariation GWASDB The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. 21051598 2010
AIDS, PROGRESSION TO
CUI: C1836233
Disease: AIDS, PROGRESSION TO
0.800 GeneticVariation GWASCAT The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. 21051598 2010
ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO
0.800 GeneticVariation GWASCAT The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. 21051598 2010
HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO
0.800 GeneticVariation GWASDB Common genetic variation and the control of HIV-1 in humans. 20041166 2009
AIDS, PROGRESSION TO
CUI: C1836233
Disease: AIDS, PROGRESSION TO
0.800 GeneticVariation GWASCAT Common genetic variation and the control of HIV-1 in humans. 20041166 2009
AIDS, PROGRESSION TO
CUI: C1836233
Disease: AIDS, PROGRESSION TO
0.800 GeneticVariation GWASDB Common genetic variation and the control of HIV-1 in humans. 20041166 2009
HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO
0.800 GeneticVariation GWASCAT Common genetic variation and the control of HIV-1 in humans. 20041166 2009
HIV-1, RESISTANCE TO
CUI: C1836231
Disease: HIV-1, RESISTANCE TO
0.800 GeneticVariation GWASCAT Common genetic variation and the control of HIV-1 in humans. 20041166 2009
ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO
0.800 GeneticVariation GWASCAT Common genetic variation and the control of HIV-1 in humans. 20041166 2009
ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO
0.800 GeneticVariation GWASDB Common genetic variation and the control of HIV-1 in humans. 20041166 2009
HIV-1, RESISTANCE TO
CUI: C1836231
Disease: HIV-1, RESISTANCE TO
0.800 GeneticVariation GWASDB Common genetic variation and the control of HIV-1 in humans. 20041166 2009
IGA Glomerulonephritis
CUI: C0017661
Disease: IGA Glomerulonephritis
0.700 GeneticVariation GWASDB A genome-wide association study in Han Chinese identifies multiple susceptibility loci for IgA nephropathy. 22197929 2011
HIV-1 VIREMIA, SUSCEPTIBILITY TO
CUI: C4016207
Disease: HIV-1 VIREMIA, SUSCEPTIBILITY TO
0.700 SusceptibilityMutation CLINVAR
Hepatitis C
CUI: C0019196
Disease: Hepatitis C
0.010 GeneticVariation BEFREE In this study, we examined the impact of the rs9264942 single-nucleotide polymorphism, previously shown to be associated with human immunodeficiency virus infection status and HLA-C expression, on the hepatitis C virus status in 359 people who inject drugs (PWID). 30102364 2018
HIV-1 infection
CUI: C2363741
Disease: HIV-1 infection
0.010 GeneticVariation BEFREE We evaluated the distribution of HLA-C (rs10484554, rs9264942) and ZNRD1 (rs8321) and ZNRD1-AS1 (rs3869068), single nucleotide polymorphisms (SNPs) in 266 HIV-1-infected and 223 unexposed-uninfected individuals from Northeast Brazil and their relation to HIV-1 infection, CD4 T cells count and viral load pre-treatment. 28494720 2017
Psoriasis vulgaris
CUI: C0263361
Disease: Psoriasis vulgaris
0.010 GeneticVariation BEFREE Whether rs9264942 SNP is associated with PsV was investigated here. rs9264942T>C was genotyped in 292 PsV patients, and 254 controls using TaqMan Genotyping Assay. 24759677 2014
Autoimmune Diseases
CUI: C0004364
Disease: Autoimmune Diseases
0.010 GeneticVariation BEFREE HLA class I molecules play a role both in viral infection control and in autoimmune diseases development. rs9264942T>C polymorphism in HLA-C gene was found to impact on HLA-C surface expression level and to be associated with HIV-1 control. 24759677 2014